Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
Molecular Metabolism|December 1, 2016
Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader-Willi syndromeIbrahim Knani, Brian J Earley, Shiran Udi, et al.
Science Translational Medicine|April 29, 2011
Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight lossBlandine Laferrère, David Reilly, Sara Arias, et al.
Nature Medicine|August 12, 2025
Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final resultsZev A Wainberg, Colin D Weekes, Muhammad Furqan, et al.
Nutrition Reviews|January 14, 2024
Probiotics for adults with major depressive disorder compared with antidepressants: a systematic review and network meta-analysisShilin Zhao, Suisha Liang, Jun Tao, et al.
The Lancet. Diabetes & Endocrinology|February 6, 2023
Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trialDenice S Feig, J Johanna Sanchez, Kellie E Murphy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2010
Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancerDaniel C Danila, Michael J Morris, Johann S de Bono, et al.
Oncogene|March 10, 2004
Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancerJ E Vivienne Watson, Norman A Doggett, Donna G Albertson, et al.
Obesity Facts|November 14, 2025
Early-Onset of Obesity Model: Impact of Early-Onset Obesity on Comorbidity Risk and Life ExpectancyUrs C H Wiedemann, Erica L T van den Akker, Thomas M Barber, et al.
The Lancet. Oncology|September 22, 2012
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 studyKarim Fizazi, Howard I Scher, Arturo Molina, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2012
Pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasisDavid De Semir, Mehdi Nosrati, Vladimir Bezrookove, et al.
Pageof 21